

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | nuclear pore complex assembly (GO:0051292) | 4.79443592 |
| 2 | nuclear pore organization (GO:0006999) | 4.49666130 |
| 3 | mitotic sister chromatid cohesion (GO:0007064) | 4.42114522 |
| 4 | monoubiquitinated protein deubiquitination (GO:0035520) | 4.41412918 |
| 5 | interkinetic nuclear migration (GO:0022027) | 4.30752037 |
| 6 | protein K11-linked deubiquitination (GO:0035871) | 4.16997292 |
| 7 | cytoplasmic mRNA processing body assembly (GO:0033962) | 4.12077436 |
| 8 | presynaptic membrane assembly (GO:0097105) | 4.11887364 |
| 9 | prenylation (GO:0097354) | 3.98723425 |
| 10 | protein prenylation (GO:0018342) | 3.98723425 |
| 11 | regulation of pigment cell differentiation (GO:0050932) | 3.69161105 |
| 12 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.59244239 |
| 13 | neural tube formation (GO:0001841) | 3.58005972 |
| 14 | histone mRNA catabolic process (GO:0071044) | 3.46181145 |
| 15 | postsynaptic membrane organization (GO:0001941) | 3.42244780 |
| 16 | positive regulation of respiratory burst (GO:0060267) | 3.39590710 |
| 17 | establishment of protein localization to Golgi (GO:0072600) | 3.39106258 |
| 18 | pore complex assembly (GO:0046931) | 3.38894337 |
| 19 | histone H3-K4 trimethylation (GO:0080182) | 3.31781246 |
| 20 | developmental pigmentation (GO:0048066) | 3.31728633 |
| 21 | presynaptic membrane organization (GO:0097090) | 3.29083524 |
| 22 | cell differentiation involved in metanephros development (GO:0072202) | 3.13495169 |
| 23 | cranial nerve structural organization (GO:0021604) | 3.12235347 |
| 24 | righting reflex (GO:0060013) | 3.12120403 |
| 25 | facial nerve structural organization (GO:0021612) | 3.11311671 |
| 26 | dentate gyrus development (GO:0021542) | 3.10947012 |
| 27 | startle response (GO:0001964) | 3.09720795 |
| 28 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.09450010 |
| 29 | protein targeting to Golgi (GO:0000042) | 3.04926813 |
| 30 | regulation of germinal center formation (GO:0002634) | 3.03190530 |
| 31 | daunorubicin metabolic process (GO:0044597) | 3.03142602 |
| 32 | polyketide metabolic process (GO:0030638) | 3.03142602 |
| 33 | doxorubicin metabolic process (GO:0044598) | 3.03142602 |
| 34 | regulation of centriole replication (GO:0046599) | 3.00449445 |
| 35 | cAMP catabolic process (GO:0006198) | 2.98633093 |
| 36 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.98151397 |
| 37 | prostate gland growth (GO:0060736) | 2.95954692 |
| 38 | nucleus localization (GO:0051647) | 2.93095333 |
| 39 | genitalia morphogenesis (GO:0035112) | 2.92382704 |
| 40 | vascular smooth muscle contraction (GO:0014829) | 2.92157486 |
| 41 | negative regulation of complement activation (GO:0045916) | 2.91621913 |
| 42 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.91262983 |
| 43 | regulation of Rac protein signal transduction (GO:0035020) | 2.90565784 |
| 44 | cyclic nucleotide catabolic process (GO:0009214) | 2.88972607 |
| 45 | cellular response to ethanol (GO:0071361) | 2.88588805 |
| 46 | sister chromatid cohesion (GO:0007062) | 2.83434003 |
| 47 | positive regulation of developmental pigmentation (GO:0048087) | 2.82893443 |
| 48 | cellular response to sterol (GO:0036315) | 2.80989956 |
| 49 | retinal cone cell development (GO:0046549) | 2.79824202 |
| 50 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.78997766 |
| 51 | regulation of relaxation of muscle (GO:1901077) | 2.76811769 |
| 52 | olfactory bulb development (GO:0021772) | 2.75072852 |
| 53 | protein heterotetramerization (GO:0051290) | 2.74959316 |
| 54 | photoreceptor cell maintenance (GO:0045494) | 2.74606759 |
| 55 | eye photoreceptor cell differentiation (GO:0001754) | 2.74156936 |
| 56 | photoreceptor cell differentiation (GO:0046530) | 2.74156936 |
| 57 | negative regulation of protein activation cascade (GO:2000258) | 2.73574043 |
| 58 | response to pheromone (GO:0019236) | 2.72472193 |
| 59 | iron ion import (GO:0097286) | 2.69027221 |
| 60 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.67713548 |
| 61 | regulation of protein glycosylation (GO:0060049) | 2.67406231 |
| 62 | lipid translocation (GO:0034204) | 2.66743354 |
| 63 | phospholipid translocation (GO:0045332) | 2.66743354 |
| 64 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.66227444 |
| 65 | mesenchymal cell differentiation (GO:0048762) | 2.64373886 |
| 66 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.63427398 |
| 67 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.62700784 |
| 68 | Golgi to endosome transport (GO:0006895) | 2.60895045 |
| 69 | protein targeting to vacuole (GO:0006623) | 2.59760760 |
| 70 | protein targeting to lysosome (GO:0006622) | 2.59760760 |
| 71 | establishment of protein localization to vacuole (GO:0072666) | 2.59760760 |
| 72 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.59513401 |
| 73 | establishment of nucleus localization (GO:0040023) | 2.59253542 |
| 74 | regulation of cell communication by electrical coupling (GO:0010649) | 2.58881243 |
| 75 | positive regulation of muscle hypertrophy (GO:0014742) | 2.57034066 |
| 76 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.57034066 |
| 77 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.56117770 |
| 78 | energy homeostasis (GO:0097009) | 2.55407714 |
| 79 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 2.55374579 |
| 80 | central nervous system neuron axonogenesis (GO:0021955) | 2.54980591 |
| 81 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.53504864 |
| 82 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.52644888 |
| 83 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.52644888 |
| 84 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.52644888 |
| 85 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.52632749 |
| 86 | positive regulation of protein homodimerization activity (GO:0090073) | 2.52336889 |
| 87 | cell differentiation involved in kidney development (GO:0061005) | 2.52229110 |
| 88 | regulation of DNA endoreduplication (GO:0032875) | 2.51597899 |
| 89 | regulation of centrosome duplication (GO:0010824) | 2.51289299 |
| 90 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.50376536 |
| 91 | protein K48-linked deubiquitination (GO:0071108) | 2.50001751 |
| 92 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.48896121 |
| 93 | G-protein coupled receptor internalization (GO:0002031) | 2.48430238 |
| 94 | detection of other organism (GO:0098543) | 2.48413105 |
| 95 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.48208906 |
| 96 | DNA double-strand break processing (GO:0000729) | 2.48015072 |
| 97 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.47921569 |
| 98 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.45445918 |
| 99 | reflex (GO:0060004) | 2.44699101 |
| 100 | pigmentation (GO:0043473) | 2.42348480 |
| 101 | intraciliary transport (GO:0042073) | 2.42278029 |
| 102 | regulation of respiratory system process (GO:0044065) | 2.41995239 |
| 103 | androgen biosynthetic process (GO:0006702) | 2.41894568 |
| 104 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.40841480 |
| 105 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.40841480 |
| 106 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.40791838 |
| 107 | T-helper cell differentiation (GO:0042093) | 2.40299881 |
| 108 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.40299881 |
| 109 | pericardium development (GO:0060039) | 2.39123544 |
| 110 | definitive hemopoiesis (GO:0060216) | 2.38705912 |
| 111 | cilium morphogenesis (GO:0060271) | 2.35735851 |
| 112 | astrocyte development (GO:0014002) | 2.35589883 |
| 113 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.35551964 |
| 114 | melanin metabolic process (GO:0006582) | 2.35332719 |
| 115 | protein K63-linked deubiquitination (GO:0070536) | 2.35331637 |
| 116 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.34279488 |
| 117 | extracellular regulation of signal transduction (GO:1900115) | 2.32711560 |
| 118 | extracellular negative regulation of signal transduction (GO:1900116) | 2.32711560 |
| 119 | negative regulation of DNA repair (GO:0045738) | 2.32435384 |
| 120 | peptidyl-lysine trimethylation (GO:0018023) | 2.32077329 |
| 121 | microtubule anchoring (GO:0034453) | 2.32049404 |
| 122 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.31417218 |
| 123 | nucleobase catabolic process (GO:0046113) | 2.30871829 |
| 124 | nerve growth factor signaling pathway (GO:0038180) | 2.30585005 |
| 125 | mitochondrion distribution (GO:0048311) | 2.30553442 |
| 126 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.30134829 |
| 127 | relaxation of cardiac muscle (GO:0055119) | 2.29204788 |
| 128 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.29040152 |
| 129 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.29040152 |
| 130 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.29040152 |
| 131 | cellular response to cholesterol (GO:0071397) | 2.28799752 |
| 132 | fibroblast migration (GO:0010761) | 2.28464833 |
| 133 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.27612990 |
| 134 | tachykinin receptor signaling pathway (GO:0007217) | 2.27540842 |
| 135 | regulation of timing of cell differentiation (GO:0048505) | 2.27410639 |
| 136 | detection of bacterium (GO:0016045) | 2.27240258 |
| 137 | ganglion development (GO:0061548) | 2.26727193 |
| 138 | regulation of respiratory gaseous exchange (GO:0043576) | 2.26632170 |
| 139 | protein localization to Golgi apparatus (GO:0034067) | 2.26344940 |
| 140 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.26242944 |
| 141 | replicative senescence (GO:0090399) | 2.25832750 |
| 142 | replication fork processing (GO:0031297) | 2.25790424 |
| 143 | positive regulation of neurological system process (GO:0031646) | 2.25555347 |
| 144 | dorsal/ventral axis specification (GO:0009950) | 2.25305006 |
| 145 | neuron cell-cell adhesion (GO:0007158) | 2.24607869 |
| 146 | response to folic acid (GO:0051593) | 2.24501739 |
| 147 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.24450659 |
| 148 | cerebral cortex development (GO:0021987) | 2.24287195 |
| 149 | L-amino acid import (GO:0043092) | 2.24209525 |
| 150 | COPII vesicle coating (GO:0048208) | 2.24141974 |
| 151 | regulation of protein polyubiquitination (GO:1902914) | 2.23527216 |
| 152 | sympathetic nervous system development (GO:0048485) | 2.23521921 |
| 153 | centriole replication (GO:0007099) | 2.22856545 |
| 154 | early endosome to late endosome transport (GO:0045022) | 2.22289431 |
| 155 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.22152369 |
| 156 | regulation of cardiac muscle hypertrophy (GO:0010611) | 2.20906565 |
| 157 | DNA dealkylation (GO:0035510) | 2.20881181 |
| 158 | smooth muscle tissue development (GO:0048745) | 2.20311941 |
| 159 | adenosine metabolic process (GO:0046085) | 2.20299766 |
| 160 | serotonin receptor signaling pathway (GO:0007210) | 2.20186210 |
| 161 | negative regulation of neurotransmitter transport (GO:0051589) | 2.19415393 |
| 162 | omega-hydroxylase P450 pathway (GO:0097267) | 2.18294349 |
| 163 | response to epinephrine (GO:0071871) | 2.17705116 |
| 164 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.16704276 |
| 165 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 2.15940174 |
| 166 | glutamate receptor signaling pathway (GO:0007215) | 2.15724526 |
| 167 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.15536718 |
| 168 | somite development (GO:0061053) | 2.15135950 |
| 169 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 2.14003199 |
| 170 | lymphoid progenitor cell differentiation (GO:0002320) | 2.12778343 |
| 171 | limb development (GO:0060173) | 2.12393904 |
| 172 | appendage development (GO:0048736) | 2.12393904 |
| 173 | neuronal action potential propagation (GO:0019227) | 2.11128662 |
| 174 | import into cell (GO:0098657) | 2.10270946 |
| 175 | regulation of muscle hypertrophy (GO:0014743) | 2.10031084 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.87576298 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.85248955 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.45052365 |
| 4 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.65407210 |
| 5 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.62331521 |
| 6 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.60961351 |
| 7 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.58031077 |
| 8 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.45863077 |
| 9 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.39837299 |
| 10 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.36925200 |
| 11 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.35605073 |
| 12 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.32617287 |
| 13 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.20720588 |
| 14 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.19433324 |
| 15 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.01661390 |
| 16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.00437138 |
| 17 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.00082639 |
| 18 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 2.00005068 |
| 19 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.93000316 |
| 20 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.88139717 |
| 21 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.87214645 |
| 22 | VDR_22108803_ChIP-Seq_LS180_Human | 1.86802496 |
| 23 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.86681252 |
| 24 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.85250076 |
| 25 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.84185103 |
| 26 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.80311812 |
| 27 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.78887315 |
| 28 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.78481685 |
| 29 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.77083472 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 1.75782481 |
| 31 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.74374579 |
| 32 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.73848646 |
| 33 | FUS_26573619_Chip-Seq_HEK293_Human | 1.70343864 |
| 34 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.68410784 |
| 35 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.64913549 |
| 36 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.61259493 |
| 37 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.60761784 |
| 38 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.60119749 |
| 39 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.59215061 |
| 40 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.57354734 |
| 41 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.54751743 |
| 42 | EWS_26573619_Chip-Seq_HEK293_Human | 1.54725296 |
| 43 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.53907107 |
| 44 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.53152430 |
| 45 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.52609849 |
| 46 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.52418827 |
| 47 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.51963987 |
| 48 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.51913303 |
| 49 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.51124271 |
| 50 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.50299911 |
| 51 | STAT3_23295773_ChIP-Seq_U87_Human | 1.50254250 |
| 52 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.46813975 |
| 53 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.45639764 |
| 54 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.45603490 |
| 55 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.43710813 |
| 56 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.43710813 |
| 57 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.43460134 |
| 58 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.43390056 |
| 59 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.43007444 |
| 60 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.41979476 |
| 61 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.41641799 |
| 62 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.41219080 |
| 63 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.39469555 |
| 64 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.39396328 |
| 65 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.37759265 |
| 66 | AR_25329375_ChIP-Seq_VCAP_Human | 1.37538374 |
| 67 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.37308735 |
| 68 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.36981177 |
| 69 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.36826155 |
| 70 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.36457467 |
| 71 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.35620204 |
| 72 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.35139348 |
| 73 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.34466953 |
| 74 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.33330622 |
| 75 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.33330622 |
| 76 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.33250251 |
| 77 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.32773167 |
| 78 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.30501145 |
| 79 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.29850147 |
| 80 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.29406260 |
| 81 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.28587611 |
| 82 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.28020250 |
| 83 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.27695159 |
| 84 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.27330217 |
| 85 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.26211702 |
| 86 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.26094175 |
| 87 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.25701452 |
| 88 | TP53_16413492_ChIP-PET_HCT116_Human | 1.25600247 |
| 89 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.25335973 |
| 90 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.25008624 |
| 91 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.24658263 |
| 92 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.24403603 |
| 93 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.24061804 |
| 94 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.23699263 |
| 95 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.23654741 |
| 96 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.23513548 |
| 97 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.22738234 |
| 98 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.22373506 |
| 99 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.22373506 |
| 100 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.21584452 |
| 101 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.21040755 |
| 102 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.20785337 |
| 103 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.19409555 |
| 104 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.19348613 |
| 105 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.18557605 |
| 106 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18557605 |
| 107 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.16941813 |
| 108 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.16624137 |
| 109 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.15825549 |
| 110 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.14792083 |
| 111 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14364610 |
| 112 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13449987 |
| 113 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.13005457 |
| 114 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.12898275 |
| 115 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.12046688 |
| 116 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.11807147 |
| 117 | * CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.11742394 |
| 118 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.11720203 |
| 119 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10881436 |
| 120 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.10732321 |
| 121 | CJUN_26792858_Chip-Seq_BT549_Human | 1.10638482 |
| 122 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.10187704 |
| 123 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.10173730 |
| 124 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.09353279 |
| 125 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.08465558 |
| 126 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.07708095 |
| 127 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.07586701 |
| 128 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.07576651 |
| 129 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.05531253 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008057_abnormal_DNA_replication | 6.00374106 |
| 2 | MP0001188_hyperpigmentation | 4.81579817 |
| 3 | MP0000569_abnormal_digit_pigmentation | 4.34737556 |
| 4 | MP0005409_darkened_coat_color | 3.87443025 |
| 5 | MP0009697_abnormal_copulation | 3.47995158 |
| 6 | MP0000015_abnormal_ear_pigmentation | 3.12273088 |
| 7 | MP0002009_preneoplasia | 2.94957463 |
| 8 | MP0003890_abnormal_embryonic-extraembry | 2.91017597 |
| 9 | MP0003136_yellow_coat_color | 2.83831855 |
| 10 | MP0004147_increased_porphyrin_level | 2.70494695 |
| 11 | MP0005174_abnormal_tail_pigmentation | 2.65206948 |
| 12 | MP0003787_abnormal_imprinting | 2.64626031 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 2.37168007 |
| 14 | MP0004381_abnormal_hair_follicle | 2.35865334 |
| 15 | MP0001986_abnormal_taste_sensitivity | 2.21105124 |
| 16 | MP0000372_irregular_coat_pigmentation | 2.17819267 |
| 17 | MP0005646_abnormal_pituitary_gland | 2.17153611 |
| 18 | MP0005645_abnormal_hypothalamus_physiol | 2.13796738 |
| 19 | MP0005171_absent_coat_pigmentation | 2.11932718 |
| 20 | MP0006292_abnormal_olfactory_placode | 2.04093996 |
| 21 | MP0002095_abnormal_skin_pigmentation | 2.01244441 |
| 22 | MP0000566_synostosis | 2.01231757 |
| 23 | MP0002876_abnormal_thyroid_physiology | 1.97555952 |
| 24 | MP0010352_gastrointestinal_tract_polyps | 1.96219117 |
| 25 | MP0010678_abnormal_skin_adnexa | 1.80684119 |
| 26 | MP0003195_calcinosis | 1.79430563 |
| 27 | MP0003880_abnormal_central_pattern | 1.78989714 |
| 28 | MP0008877_abnormal_DNA_methylation | 1.77974884 |
| 29 | MP0005075_abnormal_melanosome_morpholog | 1.67803815 |
| 30 | MP0006054_spinal_hemorrhage | 1.66950637 |
| 31 | MP0003937_abnormal_limbs/digits/tail_de | 1.62921054 |
| 32 | MP0005551_abnormal_eye_electrophysiolog | 1.62495492 |
| 33 | MP0003252_abnormal_bile_duct | 1.56195258 |
| 34 | MP0006072_abnormal_retinal_apoptosis | 1.53552745 |
| 35 | MP0004215_abnormal_myocardial_fiber | 1.50850423 |
| 36 | MP0003724_increased_susceptibility_to | 1.50837058 |
| 37 | MP0003941_abnormal_skin_development | 1.50332590 |
| 38 | MP0005379_endocrine/exocrine_gland_phen | 1.49643788 |
| 39 | MP0001486_abnormal_startle_reflex | 1.48046239 |
| 40 | MP0008058_abnormal_DNA_repair | 1.47721489 |
| 41 | MP0010386_abnormal_urinary_bladder | 1.47487883 |
| 42 | MP0005187_abnormal_penis_morphology | 1.46888760 |
| 43 | MP0002638_abnormal_pupillary_reflex | 1.45736994 |
| 44 | MP0002928_abnormal_bile_duct | 1.40178497 |
| 45 | MP0005248_abnormal_Harderian_gland | 1.37375648 |
| 46 | MP0001299_abnormal_eye_distance/ | 1.35112039 |
| 47 | MP0004084_abnormal_cardiac_muscle | 1.34861390 |
| 48 | MP0010307_abnormal_tumor_latency | 1.34248007 |
| 49 | MP0002067_abnormal_sensory_capabilities | 1.34198008 |
| 50 | MP0003183_abnormal_peptide_metabolism | 1.33406362 |
| 51 | MP0009703_decreased_birth_body | 1.31849209 |
| 52 | MP0000647_abnormal_sebaceous_gland | 1.31814473 |
| 53 | MP0009745_abnormal_behavioral_response | 1.28447055 |
| 54 | MP0001177_atelectasis | 1.26500703 |
| 55 | MP0002233_abnormal_nose_morphology | 1.24078620 |
| 56 | MP0000428_abnormal_craniofacial_morphol | 1.20683132 |
| 57 | MP0001968_abnormal_touch/_nociception | 1.20446918 |
| 58 | MP0001879_abnormal_lymphatic_vessel | 1.19776520 |
| 59 | MP0004134_abnormal_chest_morphology | 1.19628375 |
| 60 | MP0001501_abnormal_sleep_pattern | 1.19006523 |
| 61 | MP0002166_altered_tumor_susceptibility | 1.17089093 |
| 62 | MP0001502_abnormal_circadian_rhythm | 1.16819318 |
| 63 | MP0010094_abnormal_chromosome_stability | 1.15226813 |
| 64 | MP0001270_distended_abdomen | 1.15026849 |
| 65 | MP0009046_muscle_twitch | 1.14562448 |
| 66 | MP0001186_pigmentation_phenotype | 1.11993723 |
| 67 | MP0001984_abnormal_olfaction | 1.11975639 |
| 68 | MP0003656_abnormal_erythrocyte_physiolo | 1.11392851 |
| 69 | MP0002090_abnormal_vision | 1.11221695 |
| 70 | MP0002557_abnormal_social/conspecific_i | 1.11029457 |
| 71 | MP0005423_abnormal_somatic_nervous | 1.10660891 |
| 72 | MP0002177_abnormal_outer_ear | 1.09655635 |
| 73 | MP0009379_abnormal_foot_pigmentation | 1.09412357 |
| 74 | MP0002075_abnormal_coat/hair_pigmentati | 1.08358384 |
| 75 | MP0004859_abnormal_synaptic_plasticity | 1.07386908 |
| 76 | MP0003045_fibrosis | 1.07191228 |
| 77 | MP0003635_abnormal_synaptic_transmissio | 1.06177190 |
| 78 | MP0002272_abnormal_nervous_system | 1.04879519 |
| 79 | MP0004043_abnormal_pH_regulation | 1.04853387 |
| 80 | MP0003828_pulmonary_edema | 1.03055954 |
| 81 | MP0005391_vision/eye_phenotype | 1.01846091 |
| 82 | MP0003935_abnormal_craniofacial_develop | 1.00837105 |
| 83 | MP0002572_abnormal_emotion/affect_behav | 1.00822164 |
| 84 | MP0002736_abnormal_nociception_after | 1.00773841 |
| 85 | MP0002168_other_aberrant_phenotype | 1.00599877 |
| 86 | MP0006276_abnormal_autonomic_nervous | 1.00317580 |
| 87 | MP0004145_abnormal_muscle_electrophysio | 0.99524346 |
| 88 | MP0001919_abnormal_reproductive_system | 0.98841508 |
| 89 | MP0005647_abnormal_sex_gland | 0.98150418 |
| 90 | MP0002396_abnormal_hematopoietic_system | 0.96662317 |
| 91 | MP0002163_abnormal_gland_morphology | 0.95905868 |
| 92 | MP0005253_abnormal_eye_physiology | 0.95618549 |
| 93 | MP0003868_abnormal_feces_composition | 0.95295974 |
| 94 | MP0001324_abnormal_eye_pigmentation | 0.94239709 |
| 95 | MP0003633_abnormal_nervous_system | 0.94131092 |
| 96 | MP0000631_abnormal_neuroendocrine_gland | 0.93972711 |
| 97 | MP0002938_white_spotting | 0.93168015 |
| 98 | MP0002734_abnormal_mechanical_nocicepti | 0.92823643 |
| 99 | MP0009780_abnormal_chondrocyte_physiolo | 0.91630550 |
| 100 | MP0003950_abnormal_plasma_membrane | 0.91292049 |
| 101 | MP0003943_abnormal_hepatobiliary_system | 0.91286497 |
| 102 | MP0000427_abnormal_hair_cycle | 0.90901971 |
| 103 | MP0000371_diluted_coat_color | 0.89705354 |
| 104 | MP0002084_abnormal_developmental_patter | 0.89170542 |
| 105 | MP0003385_abnormal_body_wall | 0.88377612 |
| 106 | MP0005386_behavior/neurological_phenoty | 0.87988764 |
| 107 | MP0004924_abnormal_behavior | 0.87988764 |
| 108 | MP0005671_abnormal_response_to | 0.87396571 |
| 109 | MP0002006_tumorigenesis | 0.84406743 |
| 110 | MP0001835_abnormal_antigen_presentation | 0.83942784 |
| 111 | MP0000432_abnormal_head_morphology | 0.82880663 |
| 112 | MP0002088_abnormal_embryonic_growth/wei | 0.82022460 |
| 113 | MP0002735_abnormal_chemical_nociception | 0.81269924 |
| 114 | MP0004808_abnormal_hematopoietic_stem | 0.78683578 |
| 115 | MP0004270_analgesia | 0.78501857 |
| 116 | MP0004085_abnormal_heartbeat | 0.78334616 |
| 117 | MP0003984_embryonic_growth_retardation | 0.78331317 |
| 118 | MP0003632_abnormal_nervous_system | 0.77910659 |
| 119 | MP0008569_lethality_at_weaning | 0.76811439 |
| 120 | MP0001929_abnormal_gametogenesis | 0.76005538 |
| 121 | MP0003755_abnormal_palate_morphology | 0.75637281 |
| 122 | MP0000681_abnormal_thyroid_gland | 0.74954082 |
| 123 | MP0002277_abnormal_respiratory_mucosa | 0.73970291 |
| 124 | MP0000639_abnormal_adrenal_gland | 0.73593050 |
| 125 | MP0001286_abnormal_eye_development | 0.73118010 |
| 126 | MP0003631_nervous_system_phenotype | 0.72757411 |
| 127 | MP0002064_seizures | 0.72377030 |
| 128 | MP0005395_other_phenotype | 0.72345140 |
| 129 | MP0000383_abnormal_hair_follicle | 0.72267474 |
| 130 | MP0005367_renal/urinary_system_phenotyp | 0.71976085 |
| 131 | MP0000516_abnormal_urinary_system | 0.71976085 |
| 132 | MP0008007_abnormal_cellular_replicative | 0.71953730 |
| 133 | MP0004036_abnormal_muscle_relaxation | 0.71656189 |
| 134 | MP0005334_abnormal_fat_pad | 0.71562968 |
| 135 | MP0005085_abnormal_gallbladder_physiolo | 0.70698205 |
| 136 | MP0005195_abnormal_posterior_eye | 0.70460981 |
| 137 | MP0009115_abnormal_fat_cell | 0.69857390 |
| 138 | MP0002108_abnormal_muscle_morphology | 0.69280803 |
| 139 | MP0002063_abnormal_learning/memory/cond | 0.69190003 |
| 140 | MP0004142_abnormal_muscle_tone | 0.68446592 |
| 141 | MP0003690_abnormal_glial_cell | 0.68306550 |
| 142 | MP0003121_genomic_imprinting | 0.67789067 |
| 143 | MP0008260_abnormal_autophagy | 0.67700643 |
| 144 | MP0001293_anophthalmia | 0.67086466 |
| 145 | MP0005408_hypopigmentation | 0.67051284 |
| 146 | MP0000749_muscle_degeneration | 0.66849053 |
| 147 | MP0002184_abnormal_innervation | 0.65974436 |
| 148 | MP0005380_embryogenesis_phenotype | 0.65798547 |
| 149 | MP0001672_abnormal_embryogenesis/_devel | 0.65798547 |
| 150 | MP0000778_abnormal_nervous_system | 0.64374071 |
| 151 | MP0001119_abnormal_female_reproductive | 0.64012787 |
| 152 | MP0002234_abnormal_pharynx_morphology | 0.63922074 |
| 153 | MP0002102_abnormal_ear_morphology | 0.63092657 |
| 154 | MP0000579_abnormal_nail_morphology | 0.60598231 |
| 155 | MP0009764_decreased_sensitivity_to | 0.59832018 |
| 156 | MP0004484_altered_response_of | 0.59708562 |
| 157 | MP0001764_abnormal_homeostasis | 0.59703348 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Papillary thyroid carcinoma (HP:0002895) | 4.47529427 |
| 2 | Febrile seizures (HP:0002373) | 4.21378903 |
| 3 | Hypothermia (HP:0002045) | 4.20546308 |
| 4 | Fair hair (HP:0002286) | 4.01545173 |
| 5 | Generalized hypopigmentation of hair (HP:0011358) | 3.87664150 |
| 6 | Chronic hepatic failure (HP:0100626) | 3.86178856 |
| 7 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.78904455 |
| 8 | Protruding tongue (HP:0010808) | 3.46152692 |
| 9 | Chromsome breakage (HP:0040012) | 3.41524196 |
| 10 | Tubulointerstitial nephritis (HP:0001970) | 3.30827513 |
| 11 | Blue irides (HP:0000635) | 3.28122360 |
| 12 | Renal cortical cysts (HP:0000803) | 3.09802680 |
| 13 | Hyperventilation (HP:0002883) | 3.08757510 |
| 14 | Progressive cerebellar ataxia (HP:0002073) | 3.02469461 |
| 15 | Abnormality of the fingertips (HP:0001211) | 2.96635138 |
| 16 | Thyroid carcinoma (HP:0002890) | 2.95685410 |
| 17 | Gaze-evoked nystagmus (HP:0000640) | 2.92864173 |
| 18 | True hermaphroditism (HP:0010459) | 2.82796787 |
| 19 | Type I transferrin isoform profile (HP:0003642) | 2.78608552 |
| 20 | Aqueductal stenosis (HP:0002410) | 2.77186702 |
| 21 | Abnormal hair whorl (HP:0010721) | 2.70791240 |
| 22 | Absent eyebrow (HP:0002223) | 2.67522008 |
| 23 | Pheochromocytoma (HP:0002666) | 2.66071211 |
| 24 | Lip pit (HP:0100267) | 2.65448544 |
| 25 | Abnormality of incisor morphology (HP:0011063) | 2.61648654 |
| 26 | Patchy hypopigmentation of hair (HP:0011365) | 2.53362444 |
| 27 | Alveolar cell carcinoma (HP:0006519) | 2.52647583 |
| 28 | Abnormality of secondary sexual hair (HP:0009888) | 2.51956270 |
| 29 | Abnormality of the axillary hair (HP:0100134) | 2.51956270 |
| 30 | Absent speech (HP:0001344) | 2.46276753 |
| 31 | Hypoplastic labia majora (HP:0000059) | 2.44415182 |
| 32 | Congenital sensorineural hearing impairment (HP:0008527) | 2.44084601 |
| 33 | Midline defect of the nose (HP:0004122) | 2.42022832 |
| 34 | Abnormality of chromosome stability (HP:0003220) | 2.40334348 |
| 35 | Focal motor seizures (HP:0011153) | 2.39739484 |
| 36 | Oligodactyly (hands) (HP:0001180) | 2.36345551 |
| 37 | Genetic anticipation (HP:0003743) | 2.35412936 |
| 38 | Drooling (HP:0002307) | 2.34509921 |
| 39 | Excessive salivation (HP:0003781) | 2.34509921 |
| 40 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.34368956 |
| 41 | Broad-based gait (HP:0002136) | 2.32345068 |
| 42 | Intestinal atresia (HP:0011100) | 2.32162679 |
| 43 | White forelock (HP:0002211) | 2.31098126 |
| 44 | Abnormality of the ischium (HP:0003174) | 2.29666544 |
| 45 | Volvulus (HP:0002580) | 2.29143932 |
| 46 | Nonprogressive disorder (HP:0003680) | 2.28442038 |
| 47 | Abnormality of the columella (HP:0009929) | 2.27181385 |
| 48 | Poor coordination (HP:0002370) | 2.26787016 |
| 49 | Dyschromatopsia (HP:0007641) | 2.22376570 |
| 50 | Abnormality of the labia majora (HP:0012881) | 2.20442632 |
| 51 | Prostate neoplasm (HP:0100787) | 2.19659940 |
| 52 | Rhabdomyosarcoma (HP:0002859) | 2.19475600 |
| 53 | Submucous cleft hard palate (HP:0000176) | 2.16152340 |
| 54 | Abnormality of the renal medulla (HP:0100957) | 2.15620167 |
| 55 | Abnormality of the nasal septum (HP:0000419) | 2.13954436 |
| 56 | Vertebral arch anomaly (HP:0008438) | 2.13499206 |
| 57 | Glioma (HP:0009733) | 2.09890230 |
| 58 | Thyroid-stimulating hormone excess (HP:0002925) | 2.08454980 |
| 59 | Abnormality of salivation (HP:0100755) | 2.08165921 |
| 60 | Reduced antithrombin III activity (HP:0001976) | 2.06272827 |
| 61 | Epileptic encephalopathy (HP:0200134) | 2.06001766 |
| 62 | Nephronophthisis (HP:0000090) | 2.05785609 |
| 63 | Congenital primary aphakia (HP:0007707) | 2.03665500 |
| 64 | Pancreatic fibrosis (HP:0100732) | 2.03585691 |
| 65 | Truncal obesity (HP:0001956) | 2.03422879 |
| 66 | Clubbing of toes (HP:0100760) | 2.02992798 |
| 67 | Genital tract atresia (HP:0001827) | 2.02725364 |
| 68 | Astrocytoma (HP:0009592) | 2.02388673 |
| 69 | Abnormality of the astrocytes (HP:0100707) | 2.02388673 |
| 70 | Bradycardia (HP:0001662) | 2.02018227 |
| 71 | Abolished electroretinogram (ERG) (HP:0000550) | 2.01844739 |
| 72 | Large earlobe (HP:0009748) | 2.01625858 |
| 73 | Cupped ear (HP:0000378) | 2.01537777 |
| 74 | Subacute progressive viral hepatitis (HP:0006572) | 2.00374348 |
| 75 | Low anterior hairline (HP:0000294) | 1.98680214 |
| 76 | Abnormality of the renal cortex (HP:0011035) | 1.98430773 |
| 77 | Gait imbalance (HP:0002141) | 1.98052000 |
| 78 | Abnormal biliary tract morphology (HP:0012440) | 1.97553317 |
| 79 | Gonadotropin excess (HP:0000837) | 1.96881521 |
| 80 | Medial flaring of the eyebrow (HP:0010747) | 1.96259777 |
| 81 | Neuroendocrine neoplasm (HP:0100634) | 1.95152086 |
| 82 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.94844774 |
| 83 | Widely spaced teeth (HP:0000687) | 1.94674355 |
| 84 | Central scotoma (HP:0000603) | 1.94429879 |
| 85 | Bile duct proliferation (HP:0001408) | 1.93591214 |
| 86 | Abnormal biliary tract physiology (HP:0012439) | 1.93591214 |
| 87 | Decreased lacrimation (HP:0000633) | 1.92395580 |
| 88 | Scanning speech (HP:0002168) | 1.92236332 |
| 89 | Pulmonic stenosis (HP:0001642) | 1.91858938 |
| 90 | Hypochromic microcytic anemia (HP:0004840) | 1.90361580 |
| 91 | Menstrual irregularities (HP:0000858) | 1.90097050 |
| 92 | Bladder carcinoma (HP:0002862) | 1.90044042 |
| 93 | Bladder neoplasm (HP:0009725) | 1.90044042 |
| 94 | Vaginal atresia (HP:0000148) | 1.88783412 |
| 95 | Abnormality of the renal collecting system (HP:0004742) | 1.88699299 |
| 96 | Agitation (HP:0000713) | 1.88318434 |
| 97 | Neoplasm of the small intestine (HP:0100833) | 1.87612269 |
| 98 | Stomach cancer (HP:0012126) | 1.87038380 |
| 99 | Relative macrocephaly (HP:0004482) | 1.86442160 |
| 100 | Pulmonary artery stenosis (HP:0004415) | 1.86233061 |
| 101 | Ectopic kidney (HP:0000086) | 1.86079160 |
| 102 | Hypoplastic iliac wings (HP:0002866) | 1.85587039 |
| 103 | Macroorchidism (HP:0000053) | 1.85032388 |
| 104 | Congenital stationary night blindness (HP:0007642) | 1.83124505 |
| 105 | Cystic hygroma (HP:0000476) | 1.82416722 |
| 106 | Chronic diarrhea (HP:0002028) | 1.81734404 |
| 107 | Overgrowth (HP:0001548) | 1.81478221 |
| 108 | Curly hair (HP:0002212) | 1.80368135 |
| 109 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.80075881 |
| 110 | Hypoplasia of the fovea (HP:0007750) | 1.80075881 |
| 111 | Abnormality of chromosome segregation (HP:0002916) | 1.79431141 |
| 112 | Congenital hepatic fibrosis (HP:0002612) | 1.78871733 |
| 113 | Astigmatism (HP:0000483) | 1.78376711 |
| 114 | Absent frontal sinuses (HP:0002688) | 1.77338531 |
| 115 | Abnormality of midbrain morphology (HP:0002418) | 1.77319132 |
| 116 | Molar tooth sign on MRI (HP:0002419) | 1.77319132 |
| 117 | Abnormal auditory evoked potentials (HP:0006958) | 1.76859527 |
| 118 | Narrow palate (HP:0000189) | 1.76838413 |
| 119 | Highly arched eyebrow (HP:0002553) | 1.75456916 |
| 120 | Sandal gap (HP:0001852) | 1.75405214 |
| 121 | Nephrogenic diabetes insipidus (HP:0009806) | 1.75334677 |
| 122 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.74721323 |
| 123 | Abnormality of the fovea (HP:0000493) | 1.73658275 |
| 124 | Acute myeloid leukemia (HP:0004808) | 1.73079229 |
| 125 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.72554364 |
| 126 | Metaphyseal dysplasia (HP:0100255) | 1.71805492 |
| 127 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.71353276 |
| 128 | Abnormality of the right ventricle (HP:0001707) | 1.70440503 |
| 129 | Osteomalacia (HP:0002749) | 1.70261948 |
| 130 | Heterotopia (HP:0002282) | 1.70175274 |
| 131 | Pancreatic cysts (HP:0001737) | 1.69154373 |
| 132 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.68845184 |
| 133 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.68845184 |
| 134 | Cutaneous syndactyly (HP:0012725) | 1.67652438 |
| 135 | Keratoconus (HP:0000563) | 1.67384208 |
| 136 | Increased corneal curvature (HP:0100692) | 1.67384208 |
| 137 | Short chin (HP:0000331) | 1.66692612 |
| 138 | 2-3 toe syndactyly (HP:0004691) | 1.66124334 |
| 139 | Cutaneous finger syndactyly (HP:0010554) | 1.66008693 |
| 140 | Abnormality of DNA repair (HP:0003254) | 1.65973479 |
| 141 | Atonic seizures (HP:0010819) | 1.65829538 |
| 142 | Abnormality of the epiphyses of the hand (HP:0005924) | 1.65762387 |
| 143 | Long clavicles (HP:0000890) | 1.65486774 |
| 144 | Enlarged kidneys (HP:0000105) | 1.64954234 |
| 145 | Embryonal renal neoplasm (HP:0011794) | 1.64832876 |
| 146 | Attenuation of retinal blood vessels (HP:0007843) | 1.64723879 |
| 147 | Short foot (HP:0001773) | 1.64708444 |
| 148 | Pigmentary retinal degeneration (HP:0001146) | 1.64651529 |
| 149 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.63849568 |
| 150 | Gastroesophageal reflux (HP:0002020) | 1.63760620 |
| 151 | Postaxial foot polydactyly (HP:0001830) | 1.63624170 |
| 152 | Absent hair (HP:0002298) | 1.63216432 |
| 153 | Abnormality of the prostate (HP:0008775) | 1.63181765 |
| 154 | Flat occiput (HP:0005469) | 1.62786805 |
| 155 | Exotropia (HP:0000577) | 1.62114764 |
| 156 | Thyroiditis (HP:0100646) | 1.61956895 |
| 157 | Neoplasm of the thyroid gland (HP:0100031) | 1.61615005 |
| 158 | Neoplasm of striated muscle (HP:0009728) | 1.61330151 |
| 159 | Neonatal hypoglycemia (HP:0001998) | 1.61255589 |
| 160 | Hepatoblastoma (HP:0002884) | 1.61073870 |
| 161 | Severe visual impairment (HP:0001141) | 1.60838823 |
| 162 | Biliary tract neoplasm (HP:0100574) | 1.60243425 |
| 163 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.59903352 |
| 164 | Abnormality of macular pigmentation (HP:0008002) | 1.59297094 |
| 165 | Abnormality of the frontal sinuses (HP:0002687) | 1.59265396 |
| 166 | Abnormality of the nasolacrimal system (HP:0000614) | 1.59215325 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.01814293 |
| 2 | TNIK | 3.80811064 |
| 3 | MUSK | 2.97021823 |
| 4 | INSRR | 2.75182345 |
| 5 | ZAK | 2.67390124 |
| 6 | SGK2 | 2.65782233 |
| 7 | AKT3 | 2.63460350 |
| 8 | MKNK2 | 2.32965705 |
| 9 | BRSK2 | 2.30903780 |
| 10 | BMPR1B | 2.20243734 |
| 11 | WNK3 | 2.17205513 |
| 12 | NUAK1 | 2.14503304 |
| 13 | STK39 | 2.06811127 |
| 14 | MAP2K7 | 2.06292383 |
| 15 | TXK | 1.99599647 |
| 16 | YES1 | 1.90497268 |
| 17 | SGK3 | 1.81221767 |
| 18 | IRAK3 | 1.77044300 |
| 19 | SGK494 | 1.73020758 |
| 20 | SGK223 | 1.73020758 |
| 21 | FGFR2 | 1.71928530 |
| 22 | MAPK13 | 1.64740108 |
| 23 | EIF2AK2 | 1.63175671 |
| 24 | MAP3K14 | 1.61436064 |
| 25 | STK3 | 1.61233651 |
| 26 | BMPR2 | 1.56240031 |
| 27 | NLK | 1.51834974 |
| 28 | STK38L | 1.51797637 |
| 29 | NEK6 | 1.45993095 |
| 30 | PNCK | 1.42860683 |
| 31 | PDK2 | 1.38973535 |
| 32 | MAP3K6 | 1.37898730 |
| 33 | IRAK4 | 1.37562491 |
| 34 | FRK | 1.35920622 |
| 35 | MAP3K2 | 1.31780388 |
| 36 | MAP4K2 | 1.29492751 |
| 37 | CAMKK2 | 1.26838348 |
| 38 | NTRK3 | 1.26291582 |
| 39 | FGFR3 | 1.25566870 |
| 40 | WEE1 | 1.19882293 |
| 41 | TEC | 1.19527279 |
| 42 | IRAK1 | 1.16740094 |
| 43 | TAOK3 | 1.12679171 |
| 44 | MKNK1 | 1.12200701 |
| 45 | TRIM28 | 1.11892277 |
| 46 | SRPK1 | 1.10954042 |
| 47 | PIK3CA | 1.10855253 |
| 48 | MAP3K12 | 1.10485331 |
| 49 | CDK3 | 1.10124011 |
| 50 | ERBB3 | 1.06321189 |
| 51 | BRD4 | 1.04483336 |
| 52 | GRK7 | 1.02849566 |
| 53 | MARK1 | 1.02719086 |
| 54 | IRAK2 | 1.01046131 |
| 55 | SIK3 | 0.98770231 |
| 56 | PRPF4B | 0.94238806 |
| 57 | MAP3K13 | 0.94204700 |
| 58 | PRKAA2 | 0.94066731 |
| 59 | FGFR1 | 0.93670455 |
| 60 | OXSR1 | 0.92518155 |
| 61 | PAK3 | 0.92365632 |
| 62 | ERBB4 | 0.92211025 |
| 63 | SGK1 | 0.90956273 |
| 64 | PLK3 | 0.90488966 |
| 65 | KSR1 | 0.89832533 |
| 66 | MAP3K4 | 0.89339658 |
| 67 | BCR | 0.88377005 |
| 68 | CAMK1D | 0.85818635 |
| 69 | OBSCN | 0.84539906 |
| 70 | PBK | 0.83791441 |
| 71 | TIE1 | 0.81677906 |
| 72 | TRPM7 | 0.81662357 |
| 73 | CAMK1 | 0.80804733 |
| 74 | PLK4 | 0.79329093 |
| 75 | FES | 0.79177636 |
| 76 | WNK4 | 0.78654308 |
| 77 | TNK2 | 0.78499501 |
| 78 | CAMK1G | 0.76506117 |
| 79 | RIPK4 | 0.75355752 |
| 80 | MELK | 0.74962505 |
| 81 | PDGFRB | 0.74526317 |
| 82 | MAPK7 | 0.72790503 |
| 83 | GRK1 | 0.72711881 |
| 84 | UHMK1 | 0.72323476 |
| 85 | PRKCQ | 0.71296549 |
| 86 | EIF2AK3 | 0.70336304 |
| 87 | ATM | 0.69865687 |
| 88 | PRKCE | 0.69315015 |
| 89 | NEK1 | 0.69125367 |
| 90 | EPHA3 | 0.67993506 |
| 91 | EPHA4 | 0.67876082 |
| 92 | ADRBK2 | 0.66910459 |
| 93 | IKBKE | 0.66289033 |
| 94 | PINK1 | 0.62230193 |
| 95 | KIT | 0.59835104 |
| 96 | WNK1 | 0.59710722 |
| 97 | TGFBR2 | 0.58783357 |
| 98 | HIPK2 | 0.57539500 |
| 99 | CCNB1 | 0.57302569 |
| 100 | PRKD2 | 0.57007904 |
| 101 | PIK3CG | 0.54860836 |
| 102 | MARK3 | 0.53646255 |
| 103 | PDGFRA | 0.53156665 |
| 104 | TGFBR1 | 0.52369546 |
| 105 | ACVR1B | 0.51992832 |
| 106 | PKN1 | 0.51912412 |
| 107 | MAP2K4 | 0.51857829 |
| 108 | MAPKAPK5 | 0.50718826 |
| 109 | CAMK4 | 0.48587012 |
| 110 | MET | 0.48046802 |
| 111 | PRKG1 | 0.48017698 |
| 112 | CAMKK1 | 0.46672128 |
| 113 | JAK1 | 0.45856023 |
| 114 | MAPK12 | 0.45834344 |
| 115 | IGF1R | 0.45357217 |
| 116 | CDK8 | 0.45291398 |
| 117 | STK4 | 0.44763915 |
| 118 | NEK9 | 0.43558338 |
| 119 | CAMK2A | 0.43189316 |
| 120 | NTRK2 | 0.42723242 |
| 121 | CDK6 | 0.42276744 |
| 122 | PRKCH | 0.41973552 |
| 123 | LATS1 | 0.41512907 |
| 124 | CLK1 | 0.41385769 |
| 125 | CHUK | 0.40560559 |
| 126 | PRKAA1 | 0.40120717 |
| 127 | GSK3A | 0.40112239 |
| 128 | RPS6KB1 | 0.39660582 |
| 129 | EIF2AK1 | 0.39306542 |
| 130 | CSNK1G1 | 0.39277248 |
| 131 | TTK | 0.37813892 |
| 132 | FER | 0.36337811 |
| 133 | RAF1 | 0.36105187 |
| 134 | PLK2 | 0.35577953 |
| 135 | CDK9 | 0.35261858 |
| 136 | ERBB2 | 0.34670180 |
| 137 | IKBKB | 0.33929419 |
| 138 | DYRK1A | 0.33688927 |
| 139 | MAPK10 | 0.33342039 |
| 140 | CHEK1 | 0.32755975 |
| 141 | MAPK11 | 0.32506986 |
| 142 | MYLK | 0.30522746 |
| 143 | CSNK1A1L | 0.30257268 |
| 144 | VRK1 | 0.29786473 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.04156532 |
| 2 | Phototransduction_Homo sapiens_hsa04744 | 2.88091866 |
| 3 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.49305229 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.29048566 |
| 5 | Morphine addiction_Homo sapiens_hsa05032 | 2.16258235 |
| 6 | Taste transduction_Homo sapiens_hsa04742 | 2.05252416 |
| 7 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.02744357 |
| 8 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.96098429 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.94433657 |
| 10 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.94147387 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.94017513 |
| 12 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.90674627 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.81657062 |
| 14 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.80784635 |
| 15 | GABAergic synapse_Homo sapiens_hsa04727 | 1.66027238 |
| 16 | Circadian entrainment_Homo sapiens_hsa04713 | 1.63946960 |
| 17 | ABC transporters_Homo sapiens_hsa02010 | 1.62820595 |
| 18 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.52487386 |
| 19 | Circadian rhythm_Homo sapiens_hsa04710 | 1.51031502 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.47595906 |
| 21 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.42200310 |
| 22 | Olfactory transduction_Homo sapiens_hsa04740 | 1.40634545 |
| 23 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.39910568 |
| 24 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.36644692 |
| 25 | Long-term depression_Homo sapiens_hsa04730 | 1.35564386 |
| 26 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.32576709 |
| 27 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.31165551 |
| 28 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.30469976 |
| 29 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.28171472 |
| 30 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.27007123 |
| 31 | Insulin secretion_Homo sapiens_hsa04911 | 1.26127435 |
| 32 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.26068764 |
| 33 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.25470163 |
| 34 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.23070537 |
| 35 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.22946006 |
| 36 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.21489627 |
| 37 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.19963544 |
| 38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.19070689 |
| 39 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.17259094 |
| 40 | Basal transcription factors_Homo sapiens_hsa03022 | 1.16114239 |
| 41 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.15896602 |
| 42 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.15256382 |
| 43 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.14824298 |
| 44 | Salivary secretion_Homo sapiens_hsa04970 | 1.14413985 |
| 45 | Adherens junction_Homo sapiens_hsa04520 | 1.14199694 |
| 46 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.11638364 |
| 47 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.09986272 |
| 48 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.09463804 |
| 49 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.08814687 |
| 50 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.05085583 |
| 51 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.03805205 |
| 52 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.03387519 |
| 53 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.03351758 |
| 54 | Glioma_Homo sapiens_hsa05214 | 1.03052203 |
| 55 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.02606740 |
| 56 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.02276673 |
| 57 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.01725212 |
| 58 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.01700188 |
| 59 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.99775745 |
| 60 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.97885618 |
| 61 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.97102412 |
| 62 | Homologous recombination_Homo sapiens_hsa03440 | 0.96585211 |
| 63 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.96504179 |
| 64 | Renin secretion_Homo sapiens_hsa04924 | 0.96287746 |
| 65 | RNA degradation_Homo sapiens_hsa03018 | 0.96243903 |
| 66 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.94140726 |
| 67 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.93815041 |
| 68 | Lysine degradation_Homo sapiens_hsa00310 | 0.92653641 |
| 69 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.92593627 |
| 70 | Melanoma_Homo sapiens_hsa05218 | 0.89042159 |
| 71 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.88531412 |
| 72 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.88422103 |
| 73 | Endometrial cancer_Homo sapiens_hsa05213 | 0.86746715 |
| 74 | Protein export_Homo sapiens_hsa03060 | 0.86303365 |
| 75 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.85404572 |
| 76 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.84662822 |
| 77 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.83812907 |
| 78 | Long-term potentiation_Homo sapiens_hsa04720 | 0.83581968 |
| 79 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.80856776 |
| 80 | Cell cycle_Homo sapiens_hsa04110 | 0.80611412 |
| 81 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.79335277 |
| 82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79313580 |
| 83 | Measles_Homo sapiens_hsa05162 | 0.79007694 |
| 84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.78022212 |
| 85 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.77370774 |
| 86 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.76703127 |
| 87 | Colorectal cancer_Homo sapiens_hsa05210 | 0.76017778 |
| 88 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.75842925 |
| 89 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.75125410 |
| 90 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.74741326 |
| 91 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.74120479 |
| 92 | Allograft rejection_Homo sapiens_hsa05330 | 0.73947886 |
| 93 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.72280751 |
| 94 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.71894546 |
| 95 | Histidine metabolism_Homo sapiens_hsa00340 | 0.71785041 |
| 96 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.69630435 |
| 97 | Bile secretion_Homo sapiens_hsa04976 | 0.69475747 |
| 98 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.69142548 |
| 99 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.68365071 |
| 100 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.66398641 |
| 101 | Retinol metabolism_Homo sapiens_hsa00830 | 0.66176515 |
| 102 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.65481274 |
| 103 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.65467729 |
| 104 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.64933798 |
| 105 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64682704 |
| 106 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.62893130 |
| 107 | Melanogenesis_Homo sapiens_hsa04916 | 0.62641387 |
| 108 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.61778338 |
| 109 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.61600353 |
| 110 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.61458457 |
| 111 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.60278956 |
| 112 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.59921563 |
| 113 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.59415198 |
| 114 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.59243354 |
| 115 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.59151734 |
| 116 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.59121292 |
| 117 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.59025350 |
| 118 | Malaria_Homo sapiens_hsa05144 | 0.58979203 |
| 119 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.58955212 |
| 120 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.58836284 |
| 121 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.58651952 |
| 122 | Mineral absorption_Homo sapiens_hsa04978 | 0.58485808 |
| 123 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.57387370 |
| 124 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.56565054 |
| 125 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.55838552 |
| 126 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.55810162 |
| 127 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.55306158 |
| 128 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.55236208 |
| 129 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.54755437 |
| 130 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.54488681 |
| 131 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.54156347 |
| 132 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.52689654 |
| 133 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.52470037 |
| 134 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.52034944 |
| 135 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.51706299 |
| 136 | Cocaine addiction_Homo sapiens_hsa05030 | 0.51379194 |
| 137 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.51317223 |
| 138 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.51266699 |
| 139 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.51198494 |
| 140 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.51135747 |
| 141 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.50935183 |
| 142 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.50674858 |
| 143 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.50307879 |
| 144 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.49813273 |
| 145 | Prostate cancer_Homo sapiens_hsa05215 | 0.49111185 |
| 146 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.47398928 |
| 147 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.45428509 |
| 148 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.45413197 |
| 149 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.44924397 |
| 150 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44821785 |
| 151 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.43347995 |
| 152 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43072868 |
| 153 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.41853900 |
| 154 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.41764538 |
| 155 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.40954337 |
| 156 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39227464 |
| 157 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.38877041 |
| 158 | Axon guidance_Homo sapiens_hsa04360 | 0.37962726 |

